Alpa Laboratories Limited (NSE:ALPA)
India · Delayed Price · Currency is INR 62.15
-1.30 (-2.05%)
Mar 9, 2026, 3:29 PM IST
Alpa Laboratories Market Cap
Alpa Laboratories has a market cap or net worth of 1.34 billion as of March 9, 2026. Its market cap has decreased by -40.32% in one year.
Market Cap
1.34B
Enterprise Value
-54.79M
Revenue
1.14B
Ranking
n/a
PE Ratio
11.50
Stock Price
62.15
Market Cap Chart
Since August 7, 2007, Alpa Laboratories's market cap has increased from 1.15B to 1.34B, an increase of 15.78%. That is a compound annual growth rate of 0.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.31B | -20.00% |
| Dec 31, 2025 | 1.63B | -34.42% |
| Dec 31, 2024 | 2.49B | 14.68% |
| Dec 29, 2023 | 2.17B | 63.97% |
| Dec 30, 2022 | 1.33B | -20.65% |
| Dec 31, 2021 | 1.67B | 119.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 11.59B |
| Beta Drugs | 11.08B |
| Sigachi Industries | 7.40B |
| Valiant Laboratories | 2.90B |
| Bafna Pharmaceuticals | 2.65B |
| Nectar Lifesciences | 2.27B |
| Brooks Laboratories | 1.80B |
| Par Drugs and Chemicals | 1.13B |